|Title:||Targeted treatment of primary aldosteronism - The consensus of Taiwan Society of Aldosteronism||Authors:||KUO-HOW HUANG
Jeff Chueh, Shih-Chieh
|Keywords:||Guideline; Primary aldosteronism; TAIPAI||Issue Date:||Jan-2019||Publisher:||ELSEVIER TAIWAN||Journal Volume:||118||Journal Issue:||1 Pt 1||Start page/Pages:||72||Source:||Journal of the Formosan Medical Association = Taiwan yi zhi||Abstract:||
Even with the increasing recognition of primary aldosteronism (PA) as a cause of refractory hypertension and an issue of public health, the consensus of its optimal surgical or medical treatment in Taiwan has not been reached. Our objective was to develop a clinical practice guideline that is feasible for real-world management of PA patients in Taiwan.
|Appears in Collections:||醫學系|
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.